Literature DB >> 20098459

Physiological and pathological roles for microRNAs in the immune system.

Ryan M O'Connell1, Dinesh S Rao, Aadel A Chaudhuri, David Baltimore.   

Abstract

Mammalian microRNAs (miRNAs) have recently been identified as important regulators of gene expression, and they function by repressing specific target genes at the post-transcriptional level. Now, studies of miRNAs are resolving some unsolved issues in immunology. Recent studies have shown that miRNAs have unique expression profiles in cells of the innate and adaptive immune systems and have pivotal roles in the regulation of both cell development and function. Furthermore, when miRNAs are aberrantly expressed they can contribute to pathological conditions involving the immune system, such as cancer and autoimmunity; they have also been shown to be useful as diagnostic and prognostic indicators of disease type and severity. This Review discusses recent advances in our understanding of both the intended functions of miRNAs in managing immune cell biology and their pathological roles when their expression is dysregulated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20098459     DOI: 10.1038/nri2708

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  127 in total

1.  miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely.

Authors:  Beiyan Zhou; Stephanie Wang; Christine Mayr; David P Bartel; Harvey F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-16       Impact factor: 11.205

2.  MicroRNA expression profiles in umbilical cord blood cell lineages.

Authors:  Michaela Merkerova; Alzbeta Vasikova; Monika Belickova; Hana Bruchova
Journal:  Stem Cells Dev       Date:  2010-01       Impact factor: 3.272

3.  Ars2 links the nuclear cap-binding complex to RNA interference and cell proliferation.

Authors:  Joshua J Gruber; D Steven Zatechka; Leah R Sabin; Jeongsik Yong; Julian J Lum; Mei Kong; Wei-Xing Zong; Zhenxi Zhang; Chi-Kong Lau; Jason Rawlings; Sara Cherry; James N Ihle; Gideon Dreyfuss; Craig B Thompson
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

4.  Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites.

Authors:  Rickard Sandberg; Joel R Neilson; Arup Sarma; Phillip A Sharp; Christopher B Burge
Journal:  Science       Date:  2008-06-20       Impact factor: 47.728

5.  Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21.

Authors:  Frederick J Sheedy; Eva Palsson-McDermott; Elizabeth J Hennessy; Cara Martin; John J O'Leary; Qingguo Ruan; Derek S Johnson; Youhai Chen; Luke A J O'Neill
Journal:  Nat Immunol       Date:  2009-11-29       Impact factor: 25.606

6.  MicroRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN).

Authors:  Rocio T Martinez-Nunez; Fethi Louafi; Peter S Friedmann; Tilman Sanchez-Elsner
Journal:  J Biol Chem       Date:  2009-04-22       Impact factor: 5.157

7.  Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin.

Authors:  Ramiro Garzon; Michela Garofalo; Maria Paola Martelli; Roger Briesewitz; Lisheng Wang; Cecilia Fernandez-Cymering; Stefano Volinia; Chang-Gong Liu; Susanne Schnittger; Torsten Haferlach; Arcangelo Liso; Daniela Diverio; Marco Mancini; Giovanna Meloni; Robin Foa; Massimo F Martelli; Cristina Mecucci; Carlo M Croce; Brunangelo Falini
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-28       Impact factor: 11.205

8.  miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses.

Authors:  Gang Liu; Arnaud Friggeri; Yanping Yang; Young-Jun Park; Yuko Tsuruta; Edward Abraham
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-31       Impact factor: 11.205

9.  Posttranscriptional regulation of interleukin-10 expression by hsa-miR-106a.

Authors:  Amit Sharma; Manish Kumar; Jyotirmoi Aich; Manoj Hariharan; Samir K Brahmachari; Anurag Agrawal; Balaram Ghosh
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-23       Impact factor: 11.205

10.  Differential micro RNA expression in PBMC from multiple sclerosis patients.

Authors:  David Otaegui; Sergio E Baranzini; Ruben Armañanzas; Borja Calvo; Maider Muñoz-Culla; Puya Khankhanian; Iñaki Inza; Jose A Lozano; Tamara Castillo-Triviño; Ana Asensio; Javier Olaskoaga; Adolfo López de Munain
Journal:  PLoS One       Date:  2009-07-20       Impact factor: 3.240

View more
  690 in total

1.  The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α.

Authors:  Shu Zhu; Wen Pan; Xinyang Song; Yan Liu; Xinrui Shao; Yuanjia Tang; Dong Liang; Dongyi He; Honglin Wang; Wenjun Liu; Yufang Shi; John B Harley; Nan Shen; Youcun Qian
Journal:  Nat Med       Date:  2012-07       Impact factor: 53.440

2.  Temporal expression of microRNA cluster miR-17-92 regulates effector and memory CD8+ T-cell differentiation.

Authors:  Tuoqi Wu; Andreas Wieland; Koichi Araki; Carl W Davis; Lilin Ye; J Scott Hale; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-04       Impact factor: 11.205

3.  miR26a modulates Th17/T reg balance in the EAE model of multiple sclerosis by targeting IL6.

Authors:  Rongwei Zhang; Ayong Tian; Jun Wang; Xueli Shen; Guoxian Qi; Yanqing Tang
Journal:  Neuromolecular Med       Date:  2014-11-02       Impact factor: 3.843

Review 4.  Endogenous migration modulators as parent compounds for the development of novel cardiovascular and anti-inflammatory drugs.

Authors:  Wolfgang Poller; Madlen Rother; Carsten Skurk; Carmen Scheibenbogen
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 5.  Unraveling the genetic component of systemic sclerosis.

Authors:  José Ezequiel Martín; Lara Bossini-Castillo; Javier Martín
Journal:  Hum Genet       Date:  2012-01-05       Impact factor: 4.132

6.  MicroRNA-499 rs3746444 polymorphism and autoimmune diseases risk: a meta-analysis.

Authors:  Lechun Lu; Ying Tu; Lingxin Liu; Jue Qi; Li He
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

7.  Neutrophil-induced genomic instability impedes resolution of inflammation and wound healing.

Authors:  Veronika Butin-Israeli; Triet M Bui; Hannah L Wiesolek; Lorraine Mascarenhas; Joseph J Lee; Lindsey C Mehl; Kaitlyn R Knutson; Stephen A Adam; Robert D Goldman; Arthur Beyder; Lisa Wiesmuller; Stephen B Hanauer; Ronen Sumagin
Journal:  J Clin Invest       Date:  2019-01-14       Impact factor: 14.808

Review 8.  Potential function of miRNAs in herpetic stromal keratitis.

Authors:  Sachin Mulik; Siddheshvar Bhela; Barry T Rouse
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-17       Impact factor: 4.799

9.  A myelopoiesis gene signature during remission in anti-neutrophil cytoplasm antibody-associated vasculitis does not predict relapses but seems to reflect ongoing prednisolone therapy.

Authors:  T Kurz; M Weiner; C Skoglund; S Basnet; P Eriksson; M Segelmark
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

10.  MicroRNA expression aberration in Chinese patients with relapsing remitting multiple sclerosis.

Authors:  Dan Yang; Wei-Zhi Wang; Xue-Mei Zhang; Hui Yue; Bing Li; Lin Lin; Jin Fu
Journal:  J Mol Neurosci       Date:  2013-11-12       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.